PTJ
AH

Paul Tudor Jones’s Accretive Health AH Stock Holding History

Paul Tudor Jones’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-37,600
Closed -$344K – 1603
2013
Q4 		$344K Hold
37,600
– – 0.02% 803
2013
Q3 		$343K Buy
37,600
+19,000
+102% +$189K 0.01% 527
2013
Q2 		$201K Buy
+18,600
New +$196K 0.02% 725

Other funds holding AH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

Paul Tudor Jones's AH Position: Q1 2014 in Review

Paul Tudor Jones sold out of Accretive Health (AH) in Q1 2014, closing a stake of 37,600 shares — an estimated $344K sold.

Paul Tudor Jones first reported a position in AH in Q2 2013 and held it in 3 quarters. The position peaked at $344K in Q4 2013. 66 funds tracked by Wall St. Rank hold AH as of Q1 2014.

  • Paul Tudor Jones reported no remaining Accretive Health position as of Q1 2014 after selling out during the quarter.
  • Paul Tudor Jones sold 37,600 Accretive Health shares in Q1 2014, an estimated $344K.
  • Paul Tudor Jones first reported a position in Accretive Health in Q2 2013 and held it in 3 quarters.
  • Paul Tudor Jones's Accretive Health position peaked at $344K in Q4 2013.
  • 66 funds tracked by Wall St. Rank held Accretive Health as of Q1 2014.

Based on Tudor Investment Corp's 13F filing for Q1 2014, filed 15 May 2014.